Navigation Links
Pocket Pachymeter

ProductsPocket Pachymeter
Company Quantel Medical, Inc.
Item Pocket Pachymeter
Features Powered by 4 AA batteries or an A/C adapter, you can take it to the operating room or your remote clinic. The Pocket Pachymeter connects to a standard computer printer and provides a full size printed record. Perfect for pre-op and post-op measurement for LASIK.
Description Precision that fits in the palm of your hand and measures down to 125 microns, the Pocket Pachymeter is about 8" X 4" x 2" and really does fit in a lab coat pocket or briefcase.
Info Quantel Medical, Inc.
Customer Service: (888) 660-6726
Web site: http://www.quantelmedical.com

Related medicine products :

1. Pocket Direct Ophthalmoscope
2. Pocket Red Filter
3. PocketChem UA
4. Pocket II Precision Pachymeter
5. BD Pocket Crescent Blades
6. BD Pocket Scleral Blades and Knives
7. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle in soft carrying case
8. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle
9. Welch Allyn 2.5v PocketScope Ophthalmoscope (without Handle)
10. 2.5v PocketScope with Handle and Rechargeable Battery
11. S/5 Pocket Viewer
Single piece PMMA lens, AC depth: 4.7.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack.
Medicine Products:
(Date:9/8/2008)... and Lead the Fight Against Ovarian ...wswire/ -- More than 30 years ago, L,Oreal Paris,c...te a woman,s worth and,self-esteem. In 1997, as an...raising money and awareness in the fight against o... Paris has offered hope to the tens of,thousands o...
(Date:9/8/2008)...to a mechanism whereby chemotherapy may actually a.... The research, published by Cell Press in the Sep...lps to explain why a combination of traditional ch...blood vessels might impede the devastating tumor r...emotherapy remains the most commonly employed form...
(Date:9/8/2008)...rd School of Public Health (HSPH) and their collab...r Institute (NCI) have identified a common genetic...gesting a new way to approach the biological conne...nd deficiency-related diseases. , "The news here... vitamin B12 levels," said David Hunter, the Vince...
(Date:9/8/2008)...ently reported on the risk of bone fractures among... The drugs are used to treat and reduce gastric ac...estinal issues including ulcers, gastroesophageal ...omach infections and Zollinger-Ellison Syndrome. ...mber 8, 2008 -- LegalView, the number one resource...
Breaking Medicine News(10 mins):Health News:L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008 2Health News:L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008 3Health News:L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008 4Health News:Anti-angiogenic drugs impede chemotherapy-stimulated tumor recovery 2Health News:Genetic variants associated with vitamin B12 2Health News:Genetic variants associated with vitamin B12 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 2Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 4
...d the first two head-to-head clinical trials that ...alendronate) once weekly 70mg and Actonel (risedro...bisphosphonates indicated for the treatment of ost...ed by Aventis and Procter & Gamble through the All...
...the Harvard School of Public Health now reveals th...h risks. They have found that women who care for a...coronary heart disease. The findings were reported...had collected data on caregiving and coronary hear...
... specialties, recently joined hands to demonstrate...ents. Dr. Peter Costantino, an otolaryngologist, a... tumor in Angela Carrozza’s nasal cavity and right... Clinical Oncology, nearly 38,000 cases of head an...
... long-awaiting new options in treatment, now have ... approval of the new drug, Amevive. This unique d...to-treat psoriasis. Psoriasis has been thought to ...called memory effector T cells prompt skin inflamm...
Other Medicine News:Health News:New and unique treatment for Psoriasis patients 2
(Date:9/5/2008)...FRANCISCO, Calif., Sept. 5 /PRNewswire-FirstCall/ ...on small molecule LFA-1 inhibitors,to treat inflam... (Nasdaq:,SNSS) today announced SARcode,s initiati... LFA-1 product candidate for T-cell mediated ophth... license agreement providing,SARcode with an exclu...
(Date:9/4/2008)... Australia, Sept. 4 /- Cytopia Limite... enrolment for its Phase Ib/II,study of CYT997, th...gent,in patients with an aggressive form of brain...The GBM clinical trial is the first Phase II effic...ons for the company and the second in its,suite of...
(Date:9/4/2008)... first in TaqMan(R) real-time PCR testing for the ...PLEASANTON, Calif., Sept. 4 /- The U....he Roche COBAS(R) TaqMan(R) HBV Test,the first as...d in the U.S.,The test uses Roche,s real-time PCR ...irus DNA in a patient,s blood. Doctors may use vir...
(Date:9/4/2008)..., Ala., Sept. 4 /- Southern Research ...utes of Health (NIH) has selected,the organization...aries,Probe Production Center Network (MLPCN). The...art of the Molecular Libraries Program which is,de... knowledge of the human,genome and validate future...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference 21098 1NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference 21098 2NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference 21098 3Cover The Uninsured Week and Project Healthy Living Save Lives 21093 1Cover The Uninsured Week and Project Healthy Living Save Lives 21093 2Cover The Uninsured Week and Project Healthy Living Save Lives 21093 3Pharmasset to Present at the Needham 26 Co Biotechnology and Medical Technology Conference on Wednesday June 11th 5812 1Pharmasset to Present at the Needham 26 Co Biotechnology and Medical Technology Conference on Wednesday June 11th 5812 2Genetic Engineering 26 Biotechnology News Reports on the Growing Role of Ion Channel Studies in Global Biotech R 26D 2326 1Genetic Engineering 26 Biotechnology News Reports on the Growing Role of Ion Channel Studies in Global Biotech R 26D 2326 2
...LADELPHIA, July 3, 2007-- One of the fundamental t...system – might become,its greatest vulnerabi... of Southern California. Their findings,demonstr...ate that,a technique for determining a tumor&rsquo... for diagnosing and treating,specific cancers. , ...
...ROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jul 3, 2007 ...today announced that,further clinical results from...atic hyperplasia (BPH) will be presented at the Ne...iation Meeting in,Boston in September. The paper i...ors from U.S. clinical trials of NX-107., The Comp...
Other Medicine Technology:Researchers Discover Method for Identifying How Cancer Evades the,Immune System 2Researchers Discover Method for Identifying How Cancer Evades the,Immune System 3Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting 2